Webinars
Catch the latest webinars from the 2BScientific network.
Upcoming Webinars
Beyond Next Generation: Targeted Sequencing for Challenging Samples and Novel Discovery
Join Jacob Enk. PhD, Director of Technical Customer Success and Business Development at Daicel Arbor Biosciences for an exclusive webinar hosted by their UK Distributor, 2BScientific Limited in exploring innovative targeted sequencing methodologies designed to overcome these limitations and enable high-resolution insights from recent public health studies in unlocking novel discoveries.
📆Date: 11th February 2026 | ⏰Time: 3pm to 4pm
Past Webinars
Linking Science with Vector Laboratories
Join us on December 11th at 6pm GMT to learn how Vector Laboratories’ suite of bioconjugation solutions offer speed, specificity, and scalability for discovery and development across life science tools, diagnostics, biotech, and pharmaceutical sectors.
Mastering the Art of Western Blot Interpretation.
Join our colleagues from Agrisera to learn more about:
Choose the right antibody for your experiment
Optimise sample preparation and setup
Identify and prevent false positives
Understand antibody reactivity – does recognition of recombinant protein ensure specificity in endogenous samples?
Streamlining Antibody Internalisation with Cusabio
Cancer remains one of the leading causes of death worldwide, with nearly one in six deaths attributed to it. Antibody-drug conjugates (ADCs) offer a promising therapeutic approach, but their success depends heavily on efficient antibody internalisation.
Join Dr. Ying Zhou on September 3rd 2025 at 7pm GMT, Product Manager at CUSABIO, as she unveils the potential of DT3C to transform ADC development and improve cancer treatment outcomes.
Identifying lipid nanoparticle candidates using RNA sequencing
In this webinar, Dr. Kalina Paunovska will examine these challenges involving efficient delivery of RNA therapeutics in drug discovery and present SENT-seq (Single-cell Nanoparticle Targeting-sequencing), a high-throughput, single-cell multiomic screening platform designed to quantify LNP biodistribution, mRNA translation, and transcriptomic response in vivo.The webinar will discuss how SENT-seq addresses key limitations in nanoparticle screening and supports the rational design of novel LNPs tailored to specific cell types and therapeutic applications.
Register below to book your spot at the webinar on Wednesday 13th August at 16:00 BST
